Growing evidence has unveiled associations of COMP expression with a worse outcome in several solid cancer types, including breast, prostate, colorectal, bladder, and hepatocellular carcinoma [9, 11, 12, 15, 44]. The gene discussed is COMP; the disease is hepatocellular carcinoma.